STING contributes to anti-glioma immunity via triggering type-I IFN signals in the tumor microenvironment

Meeting abstracts While type-I interferons (IFNs) play critical roles in antiviral and antitumor activity, it remains to be elucidated how type-I IFNs are produced in sterile conditions of the tumor microenvironment and directly impacts tumor-infiltrating immune cells. We report that both human and

• Publication year

  2014

• Venue

  Journal of Immunotherapy for Cancer

• Publication date

  2014-11-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1186/2051-1426-2-S3-P228PMCID 4292463
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Dendritic cell subsets in cancer immunity and tumor antigen sensing

  2023cites this paper
• HP1γ Prevents Activation of the cGAS/STING Pathway by Preserving Nuclear Envelope and Genomic Integrity in Colon Adenocarcinoma Cells

  2023cites this paper
• cGAMP the travelling messenger

  2023cites this paper
• Harnessing type I interferon-mediated immunity to target malignant brain tumors

  2023cites this paper
• Targeting cGAS/STING signaling-mediated myeloid immune cell dysfunction in TIME

  2023cites this paper
• Local immunotherapy of glioblastoma: A comprehensive review of the concept.

  2023cites this paper
• Cancer cell-specific cGAS/STING Signaling pathway in the era of advancing cancer cell biology.

  2023cites this paper
• Intratumoral STING activation causes durable immunogenic tumor eradication in the KP soft tissue sarcoma model

  2023cites this paper
• Involvement of protumor macrophages in breast cancer progression and characterization of macrophage phenotypes

  2023cites this paper
• Opposite and dynamic regulation of the interferon response in metastatic and non-metastatic breast cancer

  2023cites this paper
• Emerging role of ferroptosis in glioblastoma: Therapeutic opportunities and challenges

  2022cites this paper
• PARP inhibitor plus radiotherapy reshapes an inflamed tumor microenvironment that sensitizes small cell lung cancer to the anti-PD-1 immunotherapy.

  2022cites this paper
• Activation of Stimulation of Interferon Genes (STING) Signal and Cancer Immunotherapy

  2022cites this paper
• The multifaceted functions of cGAS

  2022cites this paper
• Therapeutic targeting of STING-TBK1-IRF3 signalling ameliorates chronic stress induced depression-like behaviours by modulating neuroinflammation and microglia phagocytosis.

  2022cites this paper
• Acquired resistance to anti-PD1 therapy in patients with NSCLC reveals changes in T cell phenotypes and MET amplification

  2022cites this paper
• Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpression

  2022cites this paper
• LC3-associated phagocytosis in bone marrow macrophages suppresses acute myeloid leukemia progression through STING activation

  2022cites this paper
• Glioblastoma Microenvironment and Cellular Interactions

  2022cites this paper
• DNA Damage and Activation of cGAS/STING Pathway Induce Tumor Microenvironment Remodeling

  2022cites this paper
• STING agonist enhances the efficacy of programmed death-ligand 1 monoclonal antibody in breast cancer immunotherapy by activating the interferon-β signalling pathway

  2022cites this paper
• Whole Blood Transcriptional Fingerprints of High-Grade Glioma and Longitudinal Tumor Evolution under Carbon Ion Radiotherapy

  2022cites this paper
• The cGAS/STING Pathway: A Novel Target for Cancer Therapy

  2022cites this paper
• Prolonged survival in patients with local chronic infection after high-grade glioma treatment: Two case reports

  2022cites this paper
• Medicinal chemistry perspective on cGAS-STING signaling pathway with small molecule inhibitors.

  2022cites this paper
• Regulation of cGAS Activity and Downstream Signaling

  2022cites this paper
• cGAS-STING pathway targeted therapies and their applications in the treatment of high-grade glioma

  2022cites this paper
• Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma

  2022cites this paper
• Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy

  2022cites this paper
• Next Steps for Immunotherapy in Glioblastoma

  2022cites this paper
• Clinical significance of STING expression and methylation in lung adenocarcinoma based on bioinformatics analysis

  2022cites this paper
• Getting on in Old Age: How the Gut Microbiota Interferes With Brain Innate Immunity

  2021cites this paper
• Au naturale: use of biologically derived cyclic di-nucleotides for cancer immunotherapy

  2021cites this paper
• STINGing Viral Tumors: What We Know from Head and Neck Cancers

  2021cites this paper
• A magnetic resonance nanoprobe with STING activation character collaborates with platinum-based drug for enhanced tumor immunochemotherapy

  2021cites this paper
• STING activation promotes robust immune response and NK cell–mediated tumor regression in glioblastoma models

  2021cites this paper
• Therapeutic STING activation boosts microglia phagocytosis and ameliorates depression-like behaviors during chronic restraint stress

  2021cites this paper
• Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas

  2021cites this paper
• STING Signaling and Sterile Inflammation

  2021cites this paper
• The Challenges and Future of Immunotherapy for Gliomas

  2021cites this paper
• CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes

  2021cites this paper
• The Promise and Challenges of Cyclic Dinucleotides as Molecular Adjuvants for Vaccine Development

  2021cites this paper
• Macrophages and microglia: the cerberus of glioblastoma

  2021cites this paper
• Immune Microenvironment Landscape in CNS Tumors and Role in Responses to Immunotherapy

  2021cites this paper
• Intratumoral Delivery of STING Agonist Results in Clinical Responses in Canine Glioblastoma

  2021cites this paper
• Nanodelivery of STING agonists against cancer and infectious diseases.

  2021cites this paper
• STING suppresses bone cancer pain via immune and neuronal modulation

  2021cites this paper
• cGAS knockdown promotes microglial M2 polarization to alleviate neuroinflammation by inhibiting cGAS-STING signaling pathway in cerebral ischemic stroke.

  2021cites this paper
• Intrinsic strategies for the evasion of cGAS-STING signaling-mediated immune surveillance in human cancer: How therapy can overcome them.

  2021cites this paper
• Image-Guided Intratumoral Delivery of Immunotherapeutics in Gastrointestinal Malignancies

  2021cites this paper
• Type I and II interferons toward ideal vaccine and immunotherapy

  2021cites this paper
• A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy

  2021cites this paper
• Exploiting Radiation Therapy to Restore Immune Reactivity of Glioblastoma

  2021cites this paper
• The immune landscape of common CNS malignancies: implications for immunotherapy

  2021cites this paper
• STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer

  2021cites this paper
• Combined STING levels and CD103+ T cell infiltration have significant prognostic implications for patients with cervical cancer

  2021cites this paper
• Insights Into Dendritic Cells in Cancer Immunotherapy: From Bench to Clinical Applications

  2021cites this paper
• STING agonist and IDO inhibitor combination therapy inhibits tumor progression in murine models of colorectal cancer.

  2021cites this paper
• A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatment

  2021cites this paper
• Moonlighting Proteins Are Important Players in Cancer Immunology

  2021cites this paper
• Mitochondrial Dysfunction, Macrophage, and Microglia in Brain Cancer

  2021cites this paper
• A Nuclear Export Signal Is Required for cGAS to Sense Cytosolic DNA.

  2021cites this paper
• Immunostimulatory silica nanoparticle boosts innate immunity in brain tumors.

  2021cites this paper
• Immunotherapy and radiation for high-grade glioma: a narrative review

  2020influential citation
• Quantitative evaluation of tumor-specific T cells in tumors and lymphoid tissues.

  2020cites this paper
• Predictors of Response to Intravesical Therapy.

  2020cites this paper
• Novel therapeutics for brain tumors: current practice and future prospects

  2020cites this paper
• Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment?

  2020cites this paper
• T-Cell based therapies for overcoming neuroanatomical and immunosuppressive challenges within the glioma microenvironment

  2020cites this paper
• STING Sensing of Murine Cytomegalovirus Alters the Tumor Microenvironment to Promote Antitumor Immunity

  2020cites this paper
• A Dual Role of Type I Interferons in Antitumor Immunity

  2020cites this paper
• Research Advances in How the cGAS-STING Pathway Controls the Cellular Inflammatory Response

  2020cites this paper
• The landscape of host genetic factors involved in immune response to common viral infections

  2020cites this paper
• Glioblastoma multiforme: novel therapeutic targets

  2020cites this paper
• Stimulator of Interferon Genes Signaling Pathway and Its Role in Anti-tumor Immune Therapy.

  2020cites this paper
• Trial watch: TLR3 agonists in cancer therapy

  2020cites this paper
• Bacterial-induced cell fusion is a danger signal triggering cGAS–STING pathway via micronuclei formation

  2020cites this paper
• FIP200 Suppresses Immune Checkpoint Therapy Responses in Breast Cancers by Limiting AZI2/TBK1/IRF Signaling Independent of Its Canonical Autophagy Function

  2020cites this paper
• A review of mechanisms of resistance to immune checkpoint inhibitors and potential strategies for therapy

  2020cites this paper
• Harnessing the Complete Repertoire of Conventional Dendritic Cell Functions for Cancer Immunotherapy

  2020cites this paper
• cGAS-STING pathway in oncogenesis and cancer therapeutics

  2020cites this paper
• α-Cyperone Inhibitory Effects on Tumor-Derived DNA Trigger Microglia by STING Pathway.

  2020cites this paper
• Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy

  2020cites this paper
• Achieving efficacious immunotherapy for patients with glioblastoma

  2020cites this paper
• Overcoming immunotherapy resistance in non-small cell lung cancer (NSCLC) - novel approaches and future outlook

  2020cites this paper
• Trial watch: STING agonists in cancer therapy

  2020cites this paper
• STING regulates BCR signaling in normal and malignant B cells

  2020cites this paper
• The landscape of host genetic factors involved in immune response to common viral infections

  2020cites this paper
• Docetaxel Enhances the Expression of STING Protein in PC3 Cells, and cGAMP Attenuates this Effect

  2020cites this paper
• cGAS-STING signaling regulates control of microglia polarization in cerebral ischemic stroke

  2020cites this paper
• Design, Synthesis and Biological Evaluation of (2 (cid:48) ,5 (cid:48) and 3 (cid:48) 5 (cid:48) -Linked) cGAMP Analogs that Activate Stimulator of Interferon Genes (STING)

  2020cites this paper
• The early local and systemic Type I interferon responses to ultraviolet B light exposure are cGAS dependent

  2019cites this paper
• Activation of STING signaling accelerates skin wound healing.

  2019cites this paper
• Agonists and inhibitors of the STING pathway: Potential agents for immunotherapy

  2019cites this paper
• Intratumoral STING activations overcome negative impact of cisplatin on antitumor immunity by inflaming tumor microenvironment in squamous cell carcinoma.

  2019cites this paper
• The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma

  2019cites this paper
• Immune biology of glioma associated macrophages and microglia: Functional and therapeutic implications.

  2019cites this paper
• STING: a master regulator in the cancer-immunity cycle

  2019cites this paper
• INHIBITION OF UROTHELIAL CARCINOMA BY TYPE I INTERFERON ACTIVATION OF THE INNATE AND ADAPTIVE IMMUNE RESPONSE

  2019cites this paper
• Pharmacological modulation of nucleic acid sensors — therapeutic potential and persisting obstacles

  2019cites this paper